🔎 Trials Near Me

መነሻ › ኖን-ስማል ሴል የሳንባ ካንሰር › ፍሎሪዳ › Tampa

በTampa፣ FL ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ 51 ጥናቶች በTampa እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Moffitt Cancer Center /ID# 276785, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07155187

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT04267848

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Exelixis Clinical Site #8, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05176483

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Moffitt Cancer Center-International Plaza, Tampa
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
  • Moffitt Cancer Center - McKinley Campus, Tampa
  • እና 1 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06498635

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06625775

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffit Cancer Centre, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07659782

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • ALX Center 7, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07085091

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • H Lee Moffitt Cancer Center and Research Institute, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06765109

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04981119

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Florida Cancer Specialists, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07222566

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06667076

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06890598

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • H. Lee Moffitt Cancer Center & Research Institute, Tampa
  • Local Institution - 0647, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06875310

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • H. Lee Moffit Cancer center and research institute, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center and Research Institute, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06128551

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06745882

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07629960

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07020117

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT05681780

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • James A. Haley Veterans Hospital, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT04613596

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT04410796

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT04302025

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center-International Plaza, Tampa
  • Moffitt Cancer Center - McKinley Campus, Tampa
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07012031

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07291037

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07070232

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Moffitt Cancer Center, Tampa
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06983743

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center and Research Institute, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT07288177

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Moffitt Cancer Center, Tampa
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05317858

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffit Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT07111520

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06706076

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Moffit Cancer Center, Tampa
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT06745908

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • H Lee Moffitt Cancer Center and Research Institute, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT06162221

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • H Lee Moffitt Cancer Center and Research Institute, Tampa
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT04614103

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ጁን 2026 · NCT06216301

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT06051695

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT05076760

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT05361174

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center and Research Institute, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT04300556

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Lee Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT06917079

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሜይ 2026 · NCT05379985

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT06616584

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffit Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT04317534

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
18 Minutes · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT06031688

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኤፕሪ 2026 · NCT06841055

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኤፕሪ 2026 · NCT06010329

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Tampa
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT06682793

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Moffitt Cancer Center, Tampa
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ኖቬም 2024 · NCT04787042

በሌሎች ከተሞች ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ጥናቶች

በTampa ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።